Training overview

GE Healthcare and Institute of Clinical Physiology, National Research Council in Pisa have signed an agreement for the delivery of a newly created online tool, eduCAD, for training in appropriate use of multimodal imaging technology in cardiology in collaboration with the ESC.

eduCAD is dedicated to young physicians and doctors, and offers several clinical cases selected from the EVINCI* study.

eduCAD invites users to select different validated clinical cases, and build an optimal imaging diagnostic pathway on the basis of clinical evidence and appropriateness criteria for the use of non-invasive and invasive tests. The final conclusion and diagnostic imaging pathway is compared to the opinion of expert specialists.

A forum section allows users to give feedback and contribute clinical cases to the eduCAD team.

“Ultimately EduCAD should train cardiologists and referring physicians to choose the most appropriate diagnostic strategy for each specific patient with suspected coronary artery disease. This will reduce the use of unnecessary tests, save money and provide better care.” – says Dr Neglia, Head of the Cardiac PET‐CT Unit and Director of the Cardiovascular Imaging Program at FondazioneToscana G. Monasterio and the Institute of Clinical Physiology, National Research Council, in Pisa, Italy

Nicola Maidwell, Director of Cardiovascular Division Marketing at GE Healthcare says: “GE Healthcare is committed to support training of young physicians in appropriate use of Non-invasive cardiovascular imaging. We are delighted to be working with CNR in this important & novel digital training tool.”

Open the tool here

educad

What is the EVINCI study ?

* EVINCI - A European multi‐centre, multi‐modality cardiac imaging project funded by the European Commission within the Seventh Framework Programme Number HEALTH-F2-2009-222915. The three year trial will define the most cost effective strategy for diagnosing patients with suspected coronary artery disease. Preliminary findings from EVINCI show that the prevalence of “significant” coronary artery disease in patients with chest pain symptoms is lower than expected in Europe. In as much as 75% of this population an accurate non-invasive screening could avoid unnecessary and costly invasive procedures.